Litigation Details for Bayer Pharma AG v. Lupin Limited (D. Del. 2021)
✉ Email this page to a colleague
Bayer Pharma AG v. Lupin Limited (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-03-01 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | Laura D. Hatcher |
Patents | 7,157,456; 9,415,053; 9,539,218 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Bayer Pharma AG v. Lupin Limited
Details for Bayer Pharma AG v. Lupin Limited (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-03-01 | 4 | ANDA Form | Expiration of Patent: 1/31/2039. Thirty Month Stay Deadline: N/A* (*U.S. Patent No. 7,157,456 expires August… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 1 March 2021 1:21-cv-00314 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-12-20 | 42 | Notice of Voluntary Dismissal | Inc. as to Taro's Counterclaims as to U.S. Patent 9,415,053 (Without Prejudice) (Vrana, Robert) (Entered… 1 March 2021 1:21-cv-00314 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |